Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss

New England Journal of Medicine

Volumn 337, Issue 3, 1997, Pages 148-153

  Laskin, Carl A ^a,c,d,e   Bombardier, Claire ^a,b,f   Hannah, Mary E ^c,g   Mandel, Fred P ^c,h   Ritchie, J W Knox ^c,h   Farewell, Vern ⁱ   Farine, Dan ^c,h   Spitzer, Karen ^d   Fielding, Lynda ^d   Soloninka, Christine A ^d   Yeung, Maria ^f  

^a Division of Rheumatology   (Canada)

^b Clin Epidemiol Hlth Care Res P   (Canada)

^c Dept of Obstetrics and Gynecology ^*  (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g WOMEN S COLLEGE HOSPITAL   (Canada)

^h MOUNT SINAI HOSPITAL   (Canada)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; DNA ANTIBODY; LYMPHOCYTE ANTIBODY; PHOSPHOLIPID ANTIBODY; PREDNISONE;

ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; FEMALE; FETUS WASTAGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ABORTION, HABITUAL; ADOLESCENT; ADULT; ASPIRIN; AUTOANTIBODIES; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GLUCOCORTICOIDS; HUMANS; OBSTETRIC LABOR, PREMATURE; PREDNISONE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 0030746019     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199707173370302     Document Type: Article

References (29)

1. Friedman EA, Rutherford JW. Pregnancy and lupus erythematosus. Obstet Gynecol 1956;8:601-10.
2. Fraga A, Mintz G, Orozco J, Orozco H. Sterility and fertility rates, fetal wastage and maternal morbidity in systemic lupus erythematosus. J Rheumatol 1974;1:293-8.
3. Cecere FA, Persellin RH. The interaction of pregnancy and the rheumatic diseases. Clin Rheum Dis 1981;7:747-68.
4. Merrill JA. Cortisone in disseminated lupus erythematosus during pregnancy. Obstet Gynecol 1955;6:637-43.
5. Ramsey Goldman R. Pregnancy in systemic lupus erythematosus. Rheum Dis Clin North Am 1988;14:169-85.
6. Lubbe WF, Butler WS, Palmer SJ, Liggins GC. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet 1983;1:1361-3.
7. Branch DW, Kochenour NK, Hershgold EJ, Rote NS, Scott JR. The lupus anticoagulant - a recently discovered and treatable cause of recurrent abortion and fetal death. Am J Reprod Immunol 1984;5:100. abstract.
8. Unander AM, Norberg R, Hahn L, Arfors L. Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion. Am J Obstet Gynecol 1987;156:114-9.
9. Cronin ME, Biswas RM, Van der Straeton C, Fleisher TA, Klippel JH. IgG and IgM anticardiolipin antibodies in patients with lupus with anticardiolipin antibody associated clinical syndromes. J Rheumatol 1988;15: 795-8.
10. Harris EN, Chan JK, Asherson RA, Aber VR, Gharavi AE, Hughes GRV. Thrombosis, recurrent fetal loss, and thrombocytopenia: predictive value of the anticardiolipin antibody test. Arch Intern Med 1986;146: 2153-6.
11. Lockshin MD, Druzin ML, Goei S, et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985;313:152-6.
12. Cowchock S, Smith JB, Gocial B. Antibodies to phospholipids and nuclear antigens in patients with repeated abortions. Am J Obstet Gynecol 1986;155:1002-10.
13. Parke A, Maier D, Hakim C, Randolph J, Andreoli J. Subclinical autoimmune disease and recurrent spontaneous abortion. J Rheumatol 1986; 13:1178-80.
14. Forouzan I, Cohen AW, Lindenbaum C, Samuels P Umbilical artery and ductal blood flow velocities in patients treated with aspirin and prednisone for presence of anticardiolipin antibody. J Ultrasound Med 1993; 12:135-8.
15. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989;160:439-43.
16. Passaleva A, Massai G, D'Elios MM, Livi C, Abbate R. Prevention of miscarriage in antiphospholipid syndrome. Autoimmunity 1992;14:121-5.
17. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25: 1271-7.
18. Laskin CA, Vidins E, Blendis LM, Soloninka CA. Autoantibodies in alcoholic liver disease. Am J Med 1990;89:129-33.
19. Soloninka CA, Laskin CA, Wither J, Wong D, Bombardier C, Raboud J. Clinical utility and specificity of anticardiolipin antibodies. J Rheumatol 1991;18:1849-55.
20. Gleicher N. Pregnancy and autoimmunity. Acta Haematol 1986;76: 68-77.
21. Hawker GA, Bombardier C, Soloninka CA, et al. Autoantibodies in healthy women and in women with a history of unexplained recurrent fetal loss. Arthritis Rheum 1991;34:S95.
22. Gleicher N, el-Roeiy A, Confino E, Friberg J. Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage. Am J Obstet Gynecol 1989;160:1376-80.
23. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990;112:682-98.
24. Rai RS, Regan L, Clifford K, et al. Antiphospholipid antibodies and β2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod 1995;10:2001-5.
25. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992;166:1318-23.
26. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992;80:614-20.
27. Silver RK, MacGregor SN, Sholl JS, Hobart JM, Neerhof MG, Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993;169:1411-7.
28. Sibai BM, Caritis SN, Thom E, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 1993;329:1213-8.
29. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343:619-29.